2+ hour, 53+ min ago  (358+ words) Clinical Trials Arena According to the US Centers for Disease Control and Prevention, heart disease is the leading cause of death in the US. Coronary heart disease (CHD) is a condition where fatty deposits build up in the arteries, reducing…...

1+ day, 2+ hour ago  (384+ words) The initiative will help clinicians find dementia patients eligible for clinical trials in the UK. An initiative to boost dementia clinical trial participation has been launched in the UK. The Dementia Trials Accelerator (DTA) has invited the first participants to…...

1+ day, 3+ hour ago  (594+ words) Clinical Trials Arena Clinical depression represents a major public health challenge whose diagnosis and treatment are frequently hindered by social stigma or patient reticence to seek care. Among the countries contending with the challenge of depression care is Germany, where…...

1+ day, 7+ hour ago  (269+ words) The CRU Global-managed trial enrolled 48 subjects across five sites in three countries. Neuro Therapia has concluded its Phase IIa clinical trial of NTRX-07, an orally available molecule, for Alzheimer's disease treatment. The randomised, double-masked trial evaluated the pharmacokinetics, safety, and…...

1+ day, 8+ hour ago  (250+ words) Catal Ym has dosed the first patient in its Phase IIb GDFATHER-HCC-01 clinical trial, assessing visugromab, along with chemoimmunotherapy as a second-line treatment for patients with unresectable or metastatic hepatocellular carcinoma (HCC). The blinded, randomised, global study focuses on patients…...

2+ day, 7+ hour ago  (751+ words) In Association with Ericsson From AI applications to remote patient monitoring and mobile clinical workflows, hospitals are becoming hyper connected environments. But as healthcare accelerates toward data intensive innovation, mounting pressure on hospital networks is exposing an uncomfortable truth: many…...

2+ day, 24+ min ago  (388+ words) Sanofi's lunsekimig met its endpoints in asthma and CRSw NP but missed the primary endpoint in eczema. Two of Sanofi's lunsekimig Phase II trials have met their primary endpoints in respiratory disease, while a study in atopic dermatitis failed to…...

2+ day, 2+ hour ago  (442+ words) TRi Cares' pivotal trial will build on an ongoing early feasibility study of the Topaz TTVR system that began in January 2025. TRi Cares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to…...

2+ day, 6+ hour ago  (343+ words) The trial met its primary endpoint, demonstrating a statistically significant 77% proptosis response rate at 24 weeks. Amgen has reported positive top line results from its Phase III subcutaneous Tepezza (teprotumumab-trbw) trial in adults with moderate-to-severe active thyroid eye disease (TED). Delivered…...

2+ day, 8+ hour ago  (244+ words) Affinia Therapeutics has received approval from Health Canada for its clinical trial application (CTA) to begin the UPBEAT Phase I/II study of AFTX-201 as a treatment for Bcl2-associated athanogene 3 (BAG3)-related dilated cardiomyopathy (DCM). The open-label, multi-centre, single-arm trial will examine…...